Max Robotics — Global Service Robot Directory + US Certification

About

Renquan Ding is a thoracic surgeon and clinical researcher whose work centers on minimally invasive surgical techniques, particularly robotic-assisted thoracic surgery using the Da Vinci Surgical System. Based at the General Hospital of Shenyang Military Region, Ding has dedicated his career to advancing the adoption and evaluation of robotic and video-assisted thoracoscopic surgery (VATS) for conditions including non-small cell lung cancer (NSCLC), solitary pulmonary nodules, and mediastinal lesions. Among his notable contributions, Ding's 2018 survival analysis of 347 stage I NSCLC patients treated with Da Vinci robotic surgery — his most cited work with 5 citations — provided valuable outcome data supporting robotic surgery's clinical viability. His comparative studies between robotic-assisted and traditional VATS approaches have helped clarify the relative benefits of these techniques in terms of short-term outcomes and recovery quality. His 2023 research further extended this work by examining patients' postoperative emotional wellbeing and quality of recovery, reflecting a holistic approach to surgical outcomes assessment. While Ding's citation counts remain modest, his consistent focus on rigorous clinical evaluation of emerging surgical technologies has made him a steady contributor to the growing body of evidence guiding minimally invasive thoracic surgery practice.